S Günzelmann

Alteration of enzyme specificity by computational loop remodeling and design

Epidemiology of and Diagnostic Strategies for Toxoplasmosis

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP)

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation

Nephrotic Syndrome after Hematopoietic Cell Transplantation

Diagnosis ofToxoplasma gondiiinfection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny

Acute graft-vs-host disease

Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease

Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease

Chronic graft-versus-host disease

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Graft-versus-host disease

Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant

Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Sirolimus and Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease

Monoclonal antibodies for the prevention and treatment of graft-versus-host disease

Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant

Human mesenchymal stem cells modulate allogeneic immune cell responses

Current concepts in the diagnosis and management of cytokine release syndrome

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Bacteroides: the Good, the Bad, and the Nitty-Gritty

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

New immunosuppressants in BMT/GVHD

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA‐mismatched bone marrow transplant patients

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT

Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience